National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

MOPP regimen
A chemotherapy regimen consisting of mechlorethamine, vincristine (Oncovin), procarbazine and prednisone, used alone or in combination with radiation therapy for the treatment of stage I-IV Hodgkin lymphoma. Due to the increased risk of gonadal toxicity, this regimen has been widely replaced by the ABVD regimen. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Mustargen-Oncovin-Procarbazine-Prednisone regimen



Previous:monoclonal antibody Mik-beta-1, monoclonal antibody R24, monoclonal antibody RAV12, monoclonal antibody SGN-30, montelukast sodium
Next:Morinda citrifolia fruit extract, morphine sulfate, motesanib diphosphate, motexafin gadolinium, motexafin lutetium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov